{"id":17941,"date":"2023-11-27T12:52:26","date_gmt":"2023-11-27T17:52:26","guid":{"rendered":"https:\/\/sciencebeta.com\/?p=17941"},"modified":"2023-11-27T12:55:19","modified_gmt":"2023-11-27T17:55:19","slug":"ms-stem-cell-therapy-early-trial","status":"publish","type":"post","link":"https:\/\/sciencebeta.com\/ms-stem-cell-therapy-early-trial\/","title":{"rendered":"Stem Cell Therapy Shows Promise in Progressive Multiple Sclerosis Early Trial"},"content":{"rendered":"
A multinational group of researchers has demonstrated that injecting a particular kind of stem cell into the brains of people with progressive multiple sclerosis<\/a> (MS) is safe, well-tolerated, and produces a long-lasting effect that seems to shield the brain from additional damage. The work, led by scientists at the University of Cambridge, the University of Milan Bicocca, and the Hospital Casa Sollievo della Sofferenza (Italy), is an important step toward developing an advanced cell therapy treatment for progressive MS.<\/p>\n While treatments exist to reduce the severity and frequency of relapses, two-thirds of MS patients still progress into a debilitating secondary progressive phase of disease within 25-30 years of diagnosis, where disability worsens steadily. In multiple sclerosis, the body’s own immune system attacks and damages myelin<\/a>, the protective sheath around nerve fibers, causing disruption to messages sent around the\u00a0brain and spinal cord.<\/p>\n More than 2 million people live with MS around the world currently.<\/p>\nTransplanting Brain Stem Cells<\/h2>\n